Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109143

The Influence of Fasting, Diabetes, and Several Pharmacological Agents on the Pathways of Thyroxine Metabolism in Rat Liver

Alan Balsam, Sidney H. Ingbar, and Franklin Sexton

Thorndike Laboratory, Harvard Medical School, Boston, Massachusetts 02215

Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02215

Find articles by Balsam, A. in: PubMed | Google Scholar

Thorndike Laboratory, Harvard Medical School, Boston, Massachusetts 02215

Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02215

Find articles by Ingbar, S. in: PubMed | Google Scholar

Thorndike Laboratory, Harvard Medical School, Boston, Massachusetts 02215

Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02215

Find articles by Sexton, F. in: PubMed | Google Scholar

Published August 1, 1978 - More info

Published in Volume 62, Issue 2 on August 1, 1978
J Clin Invest. 1978;62(2):415–424. https://doi.org/10.1172/JCI109143.
© 1978 The American Society for Clinical Investigation
Published August 1, 1978 - Version history
View PDF
Abstract

As judged from both paper and column chromatography, slices or homogenates of liver from rats fasted for 48 h displayed a lesser rate of generation of 125I-labeled 3,5,3′-triiodothyronine (T3) from 125I-labeled thyroxine (T4) added to incubation media than did preparations from normal chow-fed animals. A similar defect in the conversion of T4 to T3 in the livers of fasted animals was observed when preparations were incubated with substrate concentrations of T4 so that T3 generation could be assessed by radioimmunoassay. The effect of fasting could be prevented, wholly or in part, by administration of glucose in the drinking water to otherwise fasted animals, and the degree of prevention appeared to be proportional to the concentration of glucose employed. Diminished generation of T3 from T4 was similarly evident in the livers of animals with streptozotocin-induced diabetes mellitus, and this defect was overcome by the provision of insulin in vivo, but not in vitro. Decreased formation of T3 from T4 was also observed in preparations of liver from animals given dexamethasone, amiodarone, and propylthiouracil. In no case could these effects on the net formation of T3 from T4 be explained by effects of the experimental conditions on the degradation of the T3 generated, as judged from the rate of degradation of exogenous 125I-T3 measured in parallel incubates.

An analysis of the rate of disappearance of 125I-T4 from reaction mixtures in relation to the rate of appearance of 125I-T3 and 125I-iodide was employed to estimate the activity of the 5-monodeiodinating pathway of T4 metabolism that leads to the formation of 3,3′,5′-triiodothyronine (reverse T3). Such estimates indicated that reverse T3 formation was actively proceeding in the preparations studied, was slightly enhanced by fasting, was unaffected by dexamethasone and amiodarone, and was markedly inhibited by propylthiouracil.

In view of the similarities between the effect of these experimental manipulations on the generation of T3 from T4 by rat liver in vitro to their effects on the production rates and serum concentrations of T3 in man, it is concluded that the rat liver system provides a suitable model for the study of factors that influence the conversion of T4 to T3 in man. In addition, the findings strongly indicate that this process, at least in the liver, is closely linked to the utilization of carbohydrate.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 415
page 415
icon of scanned page 416
page 416
icon of scanned page 417
page 417
icon of scanned page 418
page 418
icon of scanned page 419
page 419
icon of scanned page 420
page 420
icon of scanned page 421
page 421
icon of scanned page 422
page 422
icon of scanned page 423
page 423
icon of scanned page 424
page 424
Version history
  • Version 1 (August 1, 1978): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts